Population pharmacokinetics and pharmacodynamics of meropenem in nonobese, obese, and morbidly obese patients

EK Chung, SC Cheatham, MR Fleming… - The Journal of …, 2017 - Wiley Online Library
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …
被引用次数：34 相关文章

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients

EK Chung, SC Cheatham, MR Fleming… - The Journal of Clinical …, 2017 - infona.pl
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients

EK Chung, SC Cheatham… - Journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients

EK Chung, SC Cheatham, MR Fleming… - Journal of Clinical …, 2017 - khu.elsevierpure.com
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.

EK Chung, SC Cheatham, MR Fleming… - Journal of Clinical …, 2016 - europepmc.org
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …

Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.

EK Chung, SC Cheatham, MR Fleming… - Journal of Clinical …, 2017 - search.ebscohost.com
The study objective was to evaluate meropenem population pharmacokinetics and
pharmacodynamics in nonobese, obese, and morbidly obese patients. Forty adult patients …